News - Edison Pharmaceuticals

Filter

Current filters:

Edison Pharmaceuticals

Popular Filters

US FDA grants Edison’s EPI-743 orphan status for Friedreich's ataxia

US FDA grants Edison’s EPI-743 orphan status for Friedreich's ataxia

04-02-2014

Privately-held US pharma company Edison Pharmaceuticals has announced that the US Food and Drug Administration…

Edison PharmaceuticalsEPI-743PharmaceuticalRare diseasesRegulationUSA

Edison Pharma in deal with Dainippon Sumitomo potentially worth $4.3 billion

Edison Pharma in deal with Dainippon Sumitomo potentially worth $4.3 billion

31-01-2014

Privately-held US company Edison Pharmaceuticals has entered into a new strategic alliance valued up…

Dainippon Sumitomo PharmaEdison PharmaceuticalsEPI-589LicensingMetabolicsNeurologicalPharmaceutical

Dainippon Sumitomo gains rights to Edison Pharma drug candidates in up to $545 million accord

02-04-2013

Privately-held US firm Edison Pharmaceuticals has entered into a research, development and commercialization…

Dainippon Sumitomo PharmaEdison PharmaceuticalsEPI-589EPI-743LicensingNeurologicalPharmaceuticalResearch

Back to top